HOLX News and Press, Hologic Inc. From 11/05/20

Palm Beach, FL – November 5, 2020 – Covid-19 tests are critical in the management of the ongoing COVID-19 pandemic for accurate diagnosis as well as for tackling the spread of the infection. Over 600 SARS-CoV-2 diagnostic tests are either approved or are in the development pha...

Hologic, Inc. (HOLX) Q4 2020 Earnings Conference Call November 4, 2020 4:30 PM ET Company Participants Mike Watts - Vice President, Investor Relations and Corporate Communications Steve MacMillan - Chairman, President and Chief Executive Officer Conference Call Participants Vijay Kumar - Ever...

Image source: The Motley Fool. Hologic Inc (NASDAQ: HOLX) Q4 2020 Earnings Call Nov 4, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Hologic Inc (HOLX) Q4 2020 Earnings Call Transcript

Hologic (HOLX): Q4 Non-GAAP EPS of $2.07 beats by $0.88; GAAP EPS of $1.88 beats by $0.91.Revenue of $1.35B (+55.9% Y/Y) beats by $240M.Organic Revenue Increases 72.5%, 70.9% in Constant Currency, as Strong Sales of COVID Tests Offset Declines in Other Businesses. Shares +2.6%.Press Rele...

— Revenue of $1.347 Billion Increases 55.6%, 54.2% in Constant Currency — — Organic Revenue Increases 72.5%, 70.9% in Constant Currency, as Strong Sales of COVID Tests Offset Declines in Other Businesses — — Company Posts GAAP Diluted EPS of $1...

Hologic (NASDAQ:HOLX) is scheduled to announce Q4 earnings results on Wednesday, November 4th, after market close.The consensus EPS Estimate is $1.19 (+83.1% Y/Y) and the consensus Revenue Estimate is $1.11B (+28.2% Y/Y).Over the last 2 years, HOLX has beaten EPS estimates 63% of the time and...

Hologic (HOLX) has been awarded a ~$119.29M firm-fixed-price contract for SARS-CoV-2 molecular test production and capacity expansion, through additional equipment, material/supplies and facility infrastructure.Work is expected to be completed by January 2022.The Air Force Life Cycle Man...

- $119 Million Contract Will Support Scale Up to 13 Million Tests Per Month for U.S. Market - Hologic, Inc. (Nasdaq: HOLX) announced today that it has been awarded a $119 million contract from the United States government to expand its production capacity for COVID-19 molecu...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2020 on Wednesday, November 4, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eas...

The FDA has broadened its emergency use authorization ((EUA)) of Hologic's (HOLX) Aptima SARS-CoV-2 assay to include testing of people without symptoms or other reasons to suspect COVID-19 infection.Last week, the agency OK'd similar claims for the company's Panther Fusion SARS-CoV-2 test. ...